The DOI matches its Crossref record; 335 of the 335 references it cites were found in a registry or an index.
Metabolism of Amino Acids in Cancer
Open accessAbstract
Metabolic reprogramming has been widely recognized as a hallmark of malignancy. The uptake and metabolism of amino acids are aberrantly upregulated in many cancers that display addiction to particular amino acids. Amino acids facilitate the survival and proliferation of cancer cells under genotoxic, oxidative, and nutritional stress. Thus, targeting amino acid metabolism is becoming a potential therapeutic strategy for cancer patients. In this review, we will systematically summarize the recent progress of amino acid metabolism in malignancy and discuss their interconnection with mammalian target of rapamycin complex 1 (mTORC1) signaling, epigenetic modification, tumor growth and immunity, and ferroptosis. Finally, we will highlight the potential therapeutic applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–335 of 335
Coordinative metabolism of glutamine carbon and nitrogen in proliferating cancer cells under hypoxia
Wang, Y., Bai, C., Ruan, Y., Liu, M., Chu, Q., Qiu, L., Yang, C., & Li, B. (2019) · Nature Communications · doi:10.1038/s41467-018-08033-9 · Cited by 231
The L-Type Amino Acid Transporter LAT1—An Emerging Target in Cancer
Häfliger, P., & Charles, R.-P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102428 · Cited by 230
Diabetes and branched‐chain amino acids: What is the link?: 糖尿病与支链氨基酸:有什么关联吗?
Bloomgarden, Z. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12645 · Cited by 229
Finicle, B. T., Jayashankar, V., & Edinger, A. L. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0048-x · Cited by 228
HDAC Inhibitors in Acute Myeloid Leukemia
San José-Enériz, E., Gimenez-Camino, N., Agirre, X., & Prosper, F. (2019) · Cancers · doi:10.3390/cancers11111794 · Cited by 222
Peng, M., Yin, N., & Li, M. O. (2014) · Cell · doi:10.1016/j.cell.2014.08.038 · Cited by 220
Control of glutamine metabolism by the tumor suppressor Rb
Reynolds, M. R., Lane, A. N., Robertson, B., Kemp, S., Liu, Y., Hill, B. G., Dean, D. C., & Clem, B. F. (2014) · Oncogene · doi:10.1038/onc.2012.635 · Cited by 216 · cited 1×
“Another tumor suppressor, retinoblastoma (Rb), can directly regulate the glutamine transporter ASCT2 (SLC1A5) to reduce glutamine uptake via the transcription factor E2F3 (Reynolds et al., 2014).”
BackgroundYap reprograms glutamine metabolism to increase nucleotide biosynthesis and enable liver growth
Cox, A. G., Hwang, K. L., Brown, K. K., Evason, K. J., Beltz, S., Tsomides, A., O’Connor, K., Galli, G. G., Yimlamai, D., Chhangawala, S., et al. (2016) · Nature Cell Biology · doi:10.1038/ncb3389 · Cited by 215
Undercover: gene control by metabolites and metabolic enzymes
van der Knaap, J. A., & Verrijzer, C. P. (2016) · Genes & Development · doi:10.1101/gad.289140.116 · Cited by 214
Structure-based ligand discovery for the Large-neutral Amino Acid Transporter 1, LAT-1
Geier, E. G., Schlessinger, A., Fan, H., Gable, J. E., Irwin, J. J., Sali, A., & Giacomini, K. M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218165110 · Cited by 212
Defective autophagy leads to cancer
Edinger, A. L., & Thompson, C. B. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00306-4 · Cited by 208
HIF2α Acts as an mTORC1 Activator through the Amino Acid Carrier SLC7A5
Elorza, A., Soro-Arnáiz, I., Meléndez-Rodríguez, F., Rodríguez-Vaello, V., Marsboom, G., de Cárcer, G., Acosta-Iborra, B., Albacete-Albacete, L., Ordóñez, A., Serrano-Oviedo, L., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.09.017 · Cited by 205
L-Type amino acid transporter 1 as a target for drug delivery
Puris, E., Gynther, M., Auriola, S., & Huttunen, K. M. (2020) · Pharmaceutical Research · doi:10.1007/s11095-020-02826-8 · Cited by 205
Glutaminase Isoenzymes as Key Regulators in Metabolic and Oxidative Stress Against Cancer
Mates, J. M., Segura, J. A., Martin-Rufian, M., Campos-Sandoval, J. A., Alonso, F. J., & Marquez, J. (2013) · Current Molecular Medicine · doi:10.2174/1566524011313040005 · Cited by 203
Gayle, S., Landrette, S., Beeharry, N., Conrad, C., Hernandez, M., Beckett, P., Ferguson, S. M., Mandelkern, T., Zheng, M., Xu, T., et al. (2017) · Blood · doi:10.1182/blood-2016-09-736892 · Cited by 202
Yue, M., Jiang, J., Gao, P., Liu, H., & Qing, G. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.12.002 · Cited by 202
Nikiforov, M. A., Chandriani, S., O'Connell, B., Petrenko, O., Kotenko, I., Beavis, A., Sedivy, J. M., & Cole, M. D. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.16.5793-5800.2002 · Cited by 201
Tumor-Associated Macrophages as Target for Antitumor Therapy
Sawa-Wejksza, K., & Kandefer-Szerszeń, M. (2018) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-017-0480-8 · Cited by 201
T Cell Activation Depends on Extracellular Alanine
Ron-Harel, N., Ghergurovich, J. M., Notarangelo, G., LaFleur, M. W., Tsubosaka, Y., Sharpe, A. H., Rabinowitz, J. D., & Haigis, M. C. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.08.034 · Cited by 199
Minton, D. R., Nam, M., McLaughlin, D. J., Shin, J., Bayraktar, E. C., Alvarez, S. W., Sviderskiy, V. O., Papagiannakopoulos, T., Sabatini, D. M., Birsoy, K., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.01.024 · Cited by 196
Diet, Nutrition, and Cancer Epigenetics
Sapienza, C., & Issa, J.-P. (2016) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-121415-112634 · Cited by 194
Stracka, D., Jozefczuk, S., Rudroff, F., Sauer, U., & Hall, M. N. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.574335 · Cited by 188
Deacetylation of serine hydroxymethyl-transferase 2 by SIRT3 promotes colorectal carcinogenesis
Wei, Z., Song, J., Wang, G., Cui, X., Zheng, J., Tang, Y., Chen, X., Li, J., Cui, L., Liu, C.-Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06812-y · Cited by 185
Self-citationMetabolic Signaling to the Nucleus in Cancer
Campbell, S. L., & Wellen, K. E. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.07.015 · Cited by 181
The Metabolic Impact on Histone Acetylation and Transcription in Ageing
Peleg, S., Feller, C., Ladurner, A. G., & Imhof, A. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.05.008 · Cited by 178
Shin, D., Lee, J., You, J. H., Kim, D., & Roh, J.-L. (2020) · Redox Biology · doi:10.1016/j.redox.2019.101418 · Cited by 178
Enasidenib: First Global Approval
Kim, E. S. (2017) · Drugs · doi:10.1007/s40265-017-0813-2 · Cited by 171
Riesenberg, R., Weiler, C., Spring, O., Eder, M., Buchner, A., Popp, T., Castro, M., Kammerer, R., Takikawa, O., Hatz, R. A., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0942 · Cited by 170
Altered cancer metabolism in mechanisms of immunotherapy resistance
Ramapriyan, R., Caetano, M. S., Barsoumian, H. B., Mafra, A. C. P., Zambalde, E. P., Menon, H., Tsouko, E., Welsh, J. W., & Cortez, M. A. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.11.004 · Cited by 170
Syed, N., Langer, J., Janczar, K., Singh, P., Lo Nigro, C., Lattanzio, L., Coley, H. M., Hatzimichael, E., Bomalaski, J., Szlosarek, P., et al. (2013) · Cell Death & Disease · doi:10.1038/cddis.2012.197 · Cited by 168
Amino Acid Transporters and Glutamine Metabolism in Breast Cancer
Cha, Y., Kim, E.-S., & Koo, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030907 · Cited by 168
Tommasini-Ghelfi, S., Murnan, K., Kouri, F. M., Mahajan, A. S., May, J. L., & Stegh, A. H. (2019) · Science Advances · doi:10.1126/sciadv.aaw4543 · Cited by 168
Metabolic Inputs into the Epigenome
Sharma, U., & Rando, O. J. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.02.003 · Cited by 167
Targeting SLC1a5‐mediated glutamine dependence in non‐small cell lung cancer
Hassanein, M., Qian, J., Hoeksema, M. D., Wang, J., Jacobovitz, M., Ji, X., Harris, F. T., Harris, B. K., Boyd, K. L., Chen, H., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29535 · Cited by 166
Wang, Q., Bailey, C. G., Ng, C., Tiffen, J., Thoeng, A., Minhas, V., Lehman, M. L., Hendy, S. C., Buchanan, G., Nelson, C. C., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1821 · Cited by 165
Tap, W. D., Villalobos, V. M., Cote, G. M., Burris, H., Janku, F., Mir, O., Beeram, M., Wagner, A. J., Jiang, L., Wu, B., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.02492 · Cited by 165
Targeting the Warburg effect via LDHA inhibition engages ATF4 signaling for cancer cell survival
Pathria, G., Scott, D. A., Feng, Y., Lee, J. S., Fujita, Y., Zhang, G., Sahu, A. D., Ruppin, E., Herlyn, M., Osterman, A. L., et al. (2018) · The EMBO Journal · doi:10.15252/embj.201899735 · Cited by 164
Ren, P., Yue, M., Xiao, D., Xiu, R., Gan, L., Liu, H., & Qing, G. (2014) · The Journal of Pathology · doi:10.1002/path.4429 · Cited by 163
Sensing and Transmitting Intracellular Amino Acid Signals through Reversible Lysine Aminoacylations
He, X.-D., Gong, W., Zhang, J.-N., Nie, J., Yao, C.-F., Guo, F.-S., Lin, Y., Wu, X.-H., Li, F., Li, J., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.10.015 · Cited by 162
Ivosidenib: First Global Approval
Dhillon, S. (2018) · Drugs · doi:10.1007/s40265-018-0978-3 · Cited by 162
Ou, Y., Wang, S.-J., Jiang, L., Zheng, B., & Gu, W. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.616359 · Cited by 161
Comparative Oncogenomics Identifies PSMB4 and SHMT2 as Potential Cancer Driver Genes
Lee, G. Y., Haverty, P. M., Li, L., Kljavin, N. M., Bourgon, R., Lee, J., Stern, H., Modrusan, Z., Seshagiri, S., Zhang, Z., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2683 · Cited by 161
KDM4C and ATF4 Cooperate in Transcriptional Control of Amino Acid Metabolism
Zhao, E., Ding, J., Xia, Y., Liu, M., Ye, B., Choi, J.-H., Yan, C., Dong, Z., Huang, S., Zha, Y., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2015.12.053 · Cited by 160
Nayak-Kapoor, A., Hao, Z., Sadek, R., Dobbins, R., Marshall, L., Vahanian, N. N., Jay Ramsey, W., Kennedy, E., Mautino, M. R., Link, C. J., et al. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0351-9 · Cited by 160
Brain Insulin Lowers Circulating BCAA Levels by Inducing Hepatic BCAA Catabolism
Shin, A. C., Faßhauer, M., Filatova, N., Grundell, L. A., Zieliński, E., Zhou, J.-Y., Scherer, T., Lindtner, C., White, P. J., Lapworth, A. L., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.09.003 · Cited by 159
Targeting arginine metabolism pathway to treat arginine-dependent cancers
Qiu, F., Huang, J., & Sui, M. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.04.020 · Cited by 158
Dysregulation of the TET family of epigenetic regulators in lymphoid and myeloid malignancies
Lio, C. J., Yuita, H., & Rao, A. (2019) · Blood · doi:10.1182/blood.2019791475 · Cited by 158
Arginine Metabolism in Bacterial Pathogenesis and Cancer Therapy
Xiong, L., Teng, J. L. L., Botelho, M. G., Lo, R. C., Lau, S. K. P., & Woo, P. C. Y. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030363 · Cited by 157
Targeted inhibition of EGFR and glutaminase induces metabolic crisis in EGFR mutant lung cancer
Momcilovic, M., Bailey, S. T., Lee, J. T., Fishbein, M. C., Magyar, C., Braas, D., Graeber, T., Jackson, N. J., Czernin, J., Emberley, E., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.061 · Cited by 157
Exploiting the Epigenome to Control Cancer-Promoting Gene-Expression Programs
Brien, G. L., Valerio, D. G., & Armstrong, S. A. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.03.007 · Cited by 156
Huang, H.-Y., Wu, W.-R., Wang, Y.-H., Wang, J., Fang, F.-M., Tsai, J.-W., Li, S.-H., Hung, H.-C., Yu, S.-C., Lan, J., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2641 · Cited by 155
Glucose promotes cell growth by suppressing branched-chain amino acid degradation
Shao, D., Villet, O. M., Zhang, Z., Choi, S. W., Yan, J., Ritterhoff, J., Gu, H., Djukovic, D., Christodoulou, D. C., Kolwicz, S. C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05362-7 · Cited by 155
Arginase Inhibitors: A Rational Approach Over One Century
Pudlo, M., Demougeot, C., & Girard, C. (2016) · Medicinal Research Reviews · doi:10.1002/med.21419 · Cited by 153
Singh, N., & Ecker, G. F. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051278 · Cited by 151
DNA methylation aberrancies as a guide for surveillance and treatment of human cancers
Liang, G., & Weisenberger, D. J. (2017) · Epigenetics · doi:10.1080/15592294.2017.1311434 · Cited by 147
Chromatin-Bound MDM2 Regulates Serine Metabolism and Redox Homeostasis Independently of p53
Riscal, R., Schrepfer, E., Arena, G., Cissé, M. Y., Bellvert, F., Heuillet, M., Rambow, F., Bonneil, É., Sabourdy, F., Vincent, C., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.04.033 · Cited by 146
Understanding the role of the kynurenine pathway in human breast cancer immunobiology
Heng, B., Lim, C. K., Lovejoy, D. B., Bessede, A., Gluch, L., & Guillemin, G. J. (2015) · Oncotarget · doi:10.18632/oncotarget.6467 · Cited by 145
A phase I study of indoximod in patients with advanced malignancies
Soliman, H. H., Minton, S. E., Han, H. S., Ismail-Khan, R. R., Neuger, A. M., Khambati, F. A., Noyes, D. R., Lush, R. M., Chiappori, A., Roberts, J. D., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8216 · Cited by 145
Regulation of NK Cell Function by Human Granulocyte Arginase
Oberlies, J., Watzl, C., Giese, T., Luckner, C., Kropf, P., Müller, I., Ho, A. D., & Munder, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803523 · Cited by 144
Feng, M., Xiong, G., Cao, Z., Yang, G., Zheng, S., Qiu, J., You, L., Zheng, L., Zhang, T., & Zhao, Y. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0947-4 · Cited by 143
Delage, B., Luong, P., Maharaj, L., Ó’Riain, C., Syed, N., Crook, T., Hatzimichael, E. C., Papoudou‐Bai, A., Mitchell, T. J., Whittaker, S. J., et al. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.83 · Cited by 142
Altered exocrine function can drive adipose wasting in early pancreatic cancer
Danai, L. V., Babic, A., Rosenthal, M. H., Dennstedt, E. A., Muir, A., Lien, E. C., Mayers, J. R., Tai, K., Lau, A. N., Jones-Sali, P., et al. (2018) · Nature · doi:10.1038/s41586-018-0235-7 · Cited by 141
Lou, F., Sun, Y., Xu, Z., Niu, L., Wang, Z., Deng, S., Liu, Z., Zhou, H., Bai, J., Yin, Q., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.06.004 · Cited by 139
Rosilio, C., Nebout, M., Imbert, V., Griessinger, E., Neffati, Z., Benadiba, J., Hagenbeek, T. J., Spits, H., Reverso, J., Ambrosetti, D., et al. (2014) · Leukemia · doi:10.1038/leu.2014.338 · Cited by 136
Amengual, J. E., Lichtenstein, R., Lue, J. K., Sawas, A., Deng, C., Lichtenstein, E., Khan, K. A., Atkins, L. E., Rada, A. M., Kim, H. A., et al. (2017) · Blood · doi:10.1182/blood-2017-09-806737 · Cited by 134
Nicholson, L. J., Smith, P. R., Hiller, L., Szlosarek, P. W., Kimberley, C., Sehouli, J., Koensgen, D., Mustea, A., Schmid, P., & Crook, T. (2009) · International Journal of Cancer · doi:10.1002/ijc.24546 · Cited by 133
Lorvik, K. B., Hammarström, C. L., Fauskanger, M., Haabeth, O. A. W., Zangani, M., Haraldsen, G., Bogen, B., & Corthay, A. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-1219 · Cited by 131
Glutaminase inhibitor CB-839 synergizes with carfilzomib in resistant multiple myeloma cells
Thompson, R. M., Dytfeld, D., Reyes, L., Robinson, R. M., Smith, B. M., Manevich, Y., Jakubowiak, A. J., Komarnicki, M. A., Przybyłowicz-Chalecka, A., Szczepaniak, T., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16262 · Cited by 126
The Mechanism of End Product Inhibition of Serine Biosynthesis
Sugimoto, E., & Pizer, L. I. (1968) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)93450-2 · Cited by 121
Beddowes, E. J., Spicer, J. F., Chan, P. Y., Khadeir, R. S., Corbacho, J. G., Repana, D., Steele, J. P. C., Schmid, P., Szyszko, T. A., Cook, G., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.71.3230 · Cited by 120
Dwight, T., Benn, D. E., Clarkson, A., Vilain, R. E., Lipton, L. R., Robinson, B. G., Clifton-Bligh, R. J., & Gill, A. J. (2012) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3182671155 · Cited by 119
ATF4-Induced Metabolic Reprograming Is a Synthetic Vulnerability of the p62-Deficient Tumor Stroma
Linares, J. F., Cordes, T., Durán, Á., Reina‐Campos, M., Valencia, T., Ahn, C. S., Castilla, E. A., Moscat, J., Metallo, C. M., & Díaz-Meco, M. T. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.09.001 · Cited by 118
Folgiero, V., Goffredo, B. M., Filippini, P., Masetti, R., Bonanno, G., Caruso, R., Bertaina, V., Mastronuzzi, A., Gaspari, S., Zecca, M., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.1504 · Cited by 114
Feun, L. G., Marini, A., Walker, G., Elgart, G., Moffat, F., Rodgers, S. E., Wu, C. J., You, M., Wangpaichitr, M., Kuo, M. T., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.106 · Cited by 113
Serine biosynthesis and transport defects
El‐Hattab, A. W. (2016) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2016.04.010 · Cited by 111
Stein, E. M., Fathi, A. T., Dinardo, C. D., Pollyea, D. A., Roboz, G. J., Collins, R. H., Sekeres, M. A., Stone, R. M., Attar, E. C., Frattini, M. G., et al. (2020) · The Lancet Haematology · doi:10.1016/s2352-3026(19)30284-4 · Cited by 109
SOCS1 regulates senescence and ferroptosis by modulating the expression of p53 target genes
Saint‐Germain, E., Mignacca, L., Vernier, M., Bobbala, D., Ilangumaran, S., & Ferbeyre, G. (2017) · Aging · doi:10.18632/aging.101306 · Cited by 105
Wang, Y., Zhang, J., Ren, S., Sun, D., Huang, H., Wang, H., Jin, Y., Li, F., Zheng, C., Liu, Y., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.06.026 · Cited by 102
HDAC inhibitors overcome immunotherapy resistance in B-cell lymphoma
Wang, X., Waschke, B. C., Woolaver, R. A., Chen, S. M. Y., Chen, Z., & Wang, J. H. (2020) · Protein & Cell · doi:10.1007/s13238-020-00694-x · Cited by 102
Metzler, B., Gfeller, P., & Guinet, E. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501756 · Cited by 100
Lopez, A. B., Wang, C., Huang, C. C., Yaman, İ., Li, Y., Chakravarty, K., Johnson, P. F., Chiang, C., Snider, M. D., Wek, R. C., et al. (2007) · Biochemical Journal · doi:10.1042/bj20060941 · Cited by 96
アミノ酸代謝の阻害はヒト白血病幹細胞を選択的に標的とする【JST・京大機械翻訳】
Courtney, L., Brett, M. S., Angelo, D., Julie, A. R., Culp‐Hill, R., Travis, N., Pei, S., Khan, N., Adane, B., Ye, H., et al. (2018) · Cancer Cell · Cited by 96
García‐Navas, R., Munder, M., & Mollinedo, F. (2012) · Autophagy · doi:10.4161/auto.21315 · Cited by 93
Asparagine and Glutamine: Co-conspirators Fueling Metastasis
Luo, M., Brooks, M. D., & Wicha, M. S. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.04.012 · Cited by 92
Abdelmagid, S. A., Rickard, J. A., McDonald, W. J. F., Thomas, L. N., & Too, C. K. L. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23022 · Cited by 87
Glutamine as an Essential Amino Acid for KRas-Driven Cancer Cells
Bernfeld, E., & Foster, D. A. (2019) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2019.03.003 · Cited by 85
Nilsson, L. M., Plym Forshell, T. Z., Rimpi, S., Kreutzer, C., Pretsch, W., Bornkamm, G. W., & Nilsson, J. A. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002573 · Cited by 85
D'Amico, D. F., Antonucci, L., Magno, L. D., Coni, S., Sdruscia, G., Macone, A., Miele, E., Infante, P., Marcotullio, L. D., Smaele, E. D., et al. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.09.008 · Cited by 84
Woo, C. C., Chen, W. C., Teo, X. Q., Radda, G. K., & Lee, P. T. H. (2016) · Oncotarget · doi:10.18632/oncotarget.10415 · Cited by 83
Lü, Y., Wang, W., Wang, J., Yang, C., Mao, H.-M., Fu, X., Wu, Y., Cai, J., Han, J., Xu, Z., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073866 · Cited by 81
Control of amino acid transport coordinates metabolic reprogramming in T-cell malignancy
Grzes, K. M., Swamy, M., Hukelmann, J. L., Emslie, E., Sinclair, L. V., & Cantrell, D. A. (2017) · Leukemia · doi:10.1038/leu.2017.160 · Cited by 80
The PERK-EIF2α-ATF4 signaling branch regulates osteoblast differentiation and proliferation by PTH
Zhang, K., Wang, M., Li, Y., Li, C., Tang, S., Qu, X., Feng, N., & Wu, Y. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00371.2018 · Cited by 78
Xu, J., Jakher, Y., & Ahrens‐Nicklas, R. C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207490 · Cited by 78
GPNA inhibits the sodium-independent transport system l for neutral amino acids
Chiu, M., Sabino, C., Taurino, G., Bianchi, M. G., Andreoli, R., Giuliani, N., & Bussolati, O. (2017) · Amino Acids · doi:10.1007/s00726-017-2436-z · Cited by 77
Arginase in patients with breast cancer
Porembska, Z., Luboiński, G., Chrzanowska, A., Mielczarek‐Puta, M., Magnuska, J., & Barańczyk‐Kuźma, A. (2003) · Clinica Chimica Acta · doi:10.1016/s0009-8981(02)00391-1 · Cited by 77
Yun, D.-W., Lee, S. A., Park, M.-G., Kim, J., Yu, S., Park, M., Kim, S.-G., Oh, J., Kim, C. S., Kim, H., et al. (2014) · Journal of Pharmacological Sciences · doi:10.1254/jphs.13154fp · Cited by 76
Yanagisawa, N., Ichinoe, M., Mikami, T., Nakada, N., Hana, K., Koizumi, W., Endou, H., & Okayasu, I. (2012) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2012-200826 · Cited by 75
Metabolism and iron signaling in ferroptotic cell death
Gao, M., Monian, P., & Jiang, X. (2015) · Oncotarget · doi:10.18632/oncotarget.5671 · Cited by 71
Zhao, X., Petrashen, A. P., Sanders, J. A., Peterson, A. L., & Sedivy, J. M. (2019) · Aging Cell · doi:10.1111/acel.12947 · Cited by 69
Comprehensive Analysis of the Expressionand Prognosis for TDO2 in Breast Cancer
Liu, Q., Zhai, J., Kong, X., Wang, X., Wang, Z., Fang, Y., & Wang, J. (2020) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2020.03.013 · Cited by 68
McAlpine, J. A., Lu, H.-T., Wu, K. C., Knowles, S. K., & Thomson, J. A. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-621 · Cited by 67
Reciprocal regulation of amino acid import and epigenetic state through Lat1 and EZH2
Dann, S. G., Ryskin, M., Barsotti, A. M., Golas, J., Shi, C., Miranda, M., Hosselet, C., Lemon, L., Lucas, J., Karnoub, M., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201488166 · Cited by 67
Lan, J., Tai, H., Lee, S., Chen, T., Huang, H., & Li, C. (2013) · Tumor Biology · doi:10.1007/s13277-013-1020-8 · Cited by 66
Prognostic significance of L-type amino acid transporter 1 (LAT1) expression in cutaneous melanoma
Shimizu, A., Kaira, K., Kato, M., Yasuda, M., Takahashi, A., Tominaga, H., Oriuchi, N., Nagamori, S., Kanai, Y., Oyama, T., et al. (2015) · Melanoma Research · doi:10.1097/cmr.0000000000000181 · Cited by 64
Isoda, A., Kaira, K., Iwashina, M., Oriuchi, N., Tominaga, H., Nagamori, S., Kanai, Y., Oyama, T., Asao, T., Matsumoto, M., et al. (2014) · Cancer Science · doi:10.1111/cas.12529 · Cited by 64
Yeon, A., You, S., Kim, M., Gupta, A., Park, M. H., Weisenberger, D. J., Liang, G., & Kim, J. (2018) · Theranostics · doi:10.7150/thno.25130 · Cited by 61
Secondini, C., Coquoz, O., Spagnuolo, L., Spinetti, T., Peyvandi, S., Ciarloni, L., Botta, F., Bourquin, C., & Rüegg, C. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1316437 · Cited by 60
Hu, D., Yang, C., Lok, C., Xing, F., Lee, P., Fung, Y. M. E., Jiang, H., & Che, C. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201904131 · Cited by 59
Increased Amino Acid Uptake Supports Autophagy-Deficient Cell Survival upon Glutamine Deprivation
Zhang, N., Yang, X. P., Yuan, F., Zhang, L., Wang, Y., Wang, L., Mao, Z., Luo, J., Zhang, H., Zhu, W., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.006 · Cited by 58
Han, T., Guo, M., Zhang, T., Gan, M., Xie, C., & Wang, J.-B. (2016) · Oncotarget · doi:10.18632/oncotarget.14188 · Cited by 57
Zhuang, H., Wu, F., Wei, W., Dang, Y., Yang, B., Ma, X., Han, F., & Li, Y. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1446-z · Cited by 56
Cai, W.-F., Zhang, C., Wu, Y.-Q., 庄桂, Ye, Z., Zhang, C., & Lin, S. (2018) · Cell Research · doi:10.1038/s41422-018-0057-z · Cited by 55
Mice deficient in the Shmt2 gene have mitochondrial respiration defects and are embryonic lethal
Tani, H., Ohnishi, S., Shitara, H., Mito, T., Yamaguchi, M., Yonekawa, H., Hashizume, O., Ishikawa, K., Nakada, K., & Hayashi, J. (2018) · Scientific Reports · doi:10.1038/s41598-017-18828-3 · Cited by 54
Logiodice, F., Lombardelli, L., Kullolli, O., Haller, H., Maggi, E., Rukavina, D., & Piccinni, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020428 · Cited by 53
Decreased miR122 in hepatocellular carcinoma leads to chemoresistance with increased arginine
Kishikawa, T., Otsuka, M., Tan, P. S., Ohno, M., Sun, X., Yoshikawa, T., Shibata, C., Takata, A., Kojima, K., Takehana, K., et al. (2015) · OncoTarget · doi:10.18632/oncotarget.3234 · Cited by 51
Lu, J. L., Chen, M., Tao, Z., Gao, S., Yang, L., Cao, Y. Q., Lu, C., & Zou, X. (2017) · Oncotarget · doi:10.18632/oncotarget.19479 · Cited by 50
Chen, L., Zhang, J., Li, C., Wang, Z., Li, J., Zhao, D., Wang, S., Zhang, H., Huang, Y., & Guo, X. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.05.007 · Cited by 48
Ser, Z., Gao, X., Johnson, C., Mehrmohamadi, M., Liu, X., Li, S., & Locasale, J. W. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.05.035 · Cited by 46
Self-citationHistidine metabolism boosts cancer therapy
Frezza, C. (2018) · Nature · doi:10.1038/d41586-018-05573-4 · Cited by 46
Yao, J., Du, Z., Li, Z., Zhang, S., Lin, Y., Li, H., Zhou, L., Wang, Y., Yan, G., Wu, X., et al. (2018) · Food & Function · doi:10.1039/c8fo01147h · Cited by 44
Expression of Tryptophan 2,3-Dioxygenase in Metastatic Uveal Melanoma
Terai, M., Londin, E. R., Rochani, A., Link, E., Lam, B., Kaushal, G., Bhushan, A., Orloff, M. M., & Sato, T. (2020) · Cancers · doi:10.3390/cancers12020405 · Cited by 43
Enzymes in Metabolic Anticancer Therapy
Maggi, M., & Scotti, C. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-7709-9_9 · Cited by 41
Histone deacetylases in virus‐associated cancers
Mirzaei, H., Ghorbani, S., Khanizadeh, S., Namdari, H., Faghihloo, E., & Akbari, A. (2019) · Reviews in Medical Virology · doi:10.1002/rmv.2085 · Cited by 41
Hu, D., Yang, C., Lok, C., Xing, F., Lee, P., Fung, Y. M. E., Jiang, H., & Che, C. (2019) · Angewandte Chemie · doi:10.1002/ange.201904131 · Cited by 38
Song, M. S., Lim, S.-K., Wang, J., & Kim, H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010278 · Cited by 37
Augusto, L. D. S., Amin, P. H., Wek, R. C., & Sullivan, W. J. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007746 · Cited by 33
Immunohistochemical study of arginase in cancer of the stomach
Wu, C. W., Kao, H.-L., Lui, W. Y., Peng, F., Chung, W.-W., Chi, C.-W., & Wang, S.-R. (1996) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00202199 · Cited by 32
Wu, L., He, Y., & Zhu, L. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00169 · Cited by 32
ATP modulates SLC7A5 (LAT1) synergistically with cholesterol
Cosco, J., Scalise, M., Colas, C., Galluccio, M., Martini, R., Rovella, F., Mazza, T., Ecker, G. F., & Indiveri, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-73757-y · Cited by 31
Degradation of AMPK‐α1 sensitizes BRAF inhibitor‐resistant melanoma cells to arginine deprivation
Li, Y., Wu, C., Shah, S. S., Chen, S., Wangpaichitr, M., Kuo, M. T., Feun, L. G., Han, X., Suarez, M., Prince, J. S., et al. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12151 · Cited by 28
Zaugg, J., Huang, X. B., Ziegler, F., Rubin, M., Graff, J., Müller, J., Moser-Hässig, R., Powell, T. L., Gertsch, J., Altmann, K., et al. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15840 · Cited by 19
Analysis of SCAP N-glycosylation and Trafficking in Human Cells
Cheng, C., Guo, J. Y., Geng, F., Wu, X., Cheng, X., Li, Q., & Guo, D. (2016) · Journal of Visualized Experiments · doi:10.3791/54709 · Cited by 18
Self-citationChen, P., Wang, L., Sun, S., Zhou, Q., Zeng, Z., Hu, M., Hussain, M. S., Lu, C. C., & Du, H. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.06.061 · Cited by 17
Edick, A. M., Audette, J., & Burgos, S. A. (2020) · Journal of Dairy Science · doi:10.3168/jds.2020-18700 · Cited by 17
Duan, L., Perez, R. E., Lai, X., Chen, L., & Maki, C. G. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.007122 · Cited by 12
Cited by
Targeting glutamine metabolism as a therapeutic strategy for cancer
Jin, J., Byun, J.-K., Choi, Y.-K., & Park, K.-G. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-00971-9 · Cited by 550
Microenvironment-driven metabolic adaptations guiding CD8+ T cell anti-tumor immunity
Park, J., Hsueh, P.-C., Li, Z., & Ho, P.-C. (2023) · Immunity · doi:10.1016/j.immuni.2022.12.008 · Cited by 371
The Role of Cystine/Glutamate Antiporter SLC7A11/xCT in the Pathophysiology of Cancer
Jyotsana, N., Ta, K. T., & DelGiorno, K. E. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.858462 · Cited by 272
Goodrich, J. A., Walker, D. I., He, J., Lin, X., Baumert, B. O., Hu, X., Alderete, T. L., Chen, Z., Valvi, D., Fuentes, Z. C., et al. (2023) · Environmental Health Perspectives · doi:10.1289/ehp11372 · Cited by 96
Acute Myeloid Leukaemia Drives Metabolic Changes in the Bone Marrow Niche
Maynard, R. S., Hellmich, C., Bowles, K. M., & Rushworth, S. A. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.924567 · Cited by 17
Metadata
- Authors
- Wei, Z., Liu, X., Cheng, C., Yu, W., & Yi, P.
- Venue
- Frontiers in Cell and Developmental Biology
- Publisher
- Frontiers Media SA
- Published
- 2021-01-12
- Volume
- 8
- Pages
- 603837-603837
- ISSN
- 2296-634X (ISSN-L)
- OpenAlex
- W3118575215
- Cited by
- 429
- References
- 335
- FWCI
- 23.11
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.